Bionano Genomics (BNGO) said Monday it closed a $10 million registered direct offering of shares and warrants to purchase common stock.
The company sold about 39.7 million shares and warrants to purchase an equal amount of shares at $0.252 per share and accompanying warrant.
The warrants have an exercise price of $0.252 per share and will expire five years from the effective date of stockholder approval, the company said.
Bionano said net proceeds from the offering, along with existing cash and cash equivalents and available-for-sale securities, will be used for general corporate purposes, including working capital, research and development expenses, debt repayment and capital costs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.